Skip to content
HowShorted

Clovis Oncology, Inc. short interest in 2020

In 2020, Clovis Oncology, Inc.'s disclosed short interest ran from 37.15% of shares outstanding on 15 Jan 2020 to 41.55% on 31 Dec 2020, a change of +4.40 percentage points. The year's high was 46.78% on 31 Jan 2020 and its low 29.15% on 30 Apr 2020, averaging 39.04% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.92 days on 30 Oct 2020. Full history: Clovis Oncology, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Clovis Oncology, Inc. in 2020

2020 in figures

Start of year
37.15% (15 Jan 2020)
End of year
41.55% (31 Dec 2020)
Change
+4.40 pp
High
46.78% (31 Jan 2020)
Low
29.15% (30 Apr 2020)
Average
39.04%
Highest days to cover
13.92 (30 Oct 2020)
SEC filings marked
9

Every report in 2020

Clovis Oncology, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202037.15%3.03results (8-K)
31 Jan 202046.78%3.53
14 Feb 202046.74%4.85
28 Feb 202032.42%2.66results (8-K), 10-K filed
13 Mar 202034.92%4.93
31 Mar 202034.20%3.10
15 Apr 202031.80%5.98
30 Apr 202029.15%3.86
15 May 202034.47%3.27results (8-K), 10-Q filed
29 May 202035.42%2.54
15 Jun 202033.89%5.86
30 Jun 202039.33%6.81
15 Jul 202042.46%10.37
31 Jul 202038.45%10.42
14 Aug 202040.94%7.83results (8-K), 10-Q filed
31 Aug 202041.46%6.82
15 Sep 202042.99%7.64
30 Sep 202044.40%8.09
15 Oct 202044.66%11.04
30 Oct 202046.03%13.92
13 Nov 202044.74%7.2710-Q filed, results (8-K)
30 Nov 202038.09%8.87
15 Dec 202035.00%7.07
31 Dec 202041.55%6.36

See also: Clovis Oncology, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.